Agilent Technologies Inc
NYSE:A

Watchlist Manager
Agilent Technologies Inc Logo
Agilent Technologies Inc
NYSE:A
Watchlist
Price: 136.1 USD 1.11% Market Closed
Market Cap: 39.1B USD
Have any thoughts about
Agilent Technologies Inc?
Write Note
A
/
Balance Sheet
/
Other Liabilities

Agilent Technologies Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Agilent Technologies Inc
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Agilent Technologies Inc
NYSE:A
Other Liabilities
$708m
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
-11%
Thermo Fisher Scientific Inc
NYSE:TMO
Other Liabilities
$4.3B
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
15%
Danaher Corp
NYSE:DHR
Other Liabilities
$5.6B
CAGR 3-Years
-12%
CAGR 5-Years
-1%
CAGR 10-Years
3%
West Pharmaceutical Services Inc
NYSE:WST
Other Liabilities
$192.3m
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
4%
Mettler-Toledo International Inc
NYSE:MTD
Other Liabilities
$289.8m
CAGR 3-Years
-7%
CAGR 5-Years
-5%
CAGR 10-Years
5%
IQVIA Holdings Inc
NYSE:IQV
Other Liabilities
$800m
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
17%
No Stocks Found

Agilent Technologies Inc
Glance View

Market Cap
38.8B USD
Industry
Life Sciences Tools & Services
Economic Moat
Narrow

Agilent Technologies Inc., a spin-off from Hewlett-Packard in 1999, has cultivated a niche in the vibrant landscape of the life sciences, diagnostics, and applied chemical markets. This California-based company, born from the legacy of one of Silicon Valley’s pioneers, has carved out its identity by providing sophisticated analytical instrumentation, software, services, and consumables for a wide range of applications. Agilent's businesses are stitched together by an underlying technology expertise, which forms the bedrock for its product lines that serve an increasing demand for precise and reliable analytical measurements. From cutting-edge liquid chromatography to mass spectrometry and genetic analysis systems, Agilent's offerings are geared towards supporting research and quality control processes across various industries, including pharmaceuticals, food safety, and environmental testing. The company's commitment to innovation and quality has consistently positioned it as a trusted partner in advancing the capabilities of laboratories worldwide. Agilent's revenue generation hinges on a strategic blend of product sales and services. The core of its business model revolves around not just selling instruments, but also establishing long-term relationships through service agreements, maintenance, and training. This recurring service revenue complements the sale of consumables and parts required for the operation of their sophisticated instruments. Additionally, Agilent has strategically expanded its footprint in the diagnostics market, providing instruments and reagents used in pathology laboratories, further diversifying its income streams. With a deliberate focus on high-growth areas, including genomics and cancer diagnostics, Agilent continues to leverage its technological prowess and industry expertise to capture market share in sectors that are inherently driven by the necessity for innovation and regulatory compliance. Through an intricate balance of hardware sales and consistent after-sale support, Agilent steadily maintains its role as a formidable player in the analytical instrumentation sector.

A Intrinsic Value
116.13 USD
Overvaluation 15%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Agilent Technologies Inc's Other Liabilities?
Other Liabilities
708m USD

Based on the financial report for Oct 31, 2024, Agilent Technologies Inc's Other Liabilities amounts to 708m USD.

What is Agilent Technologies Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
-11%

Over the last year, the Other Liabilities growth was 22%. The average annual Other Liabilities growth rates for Agilent Technologies Inc have been -7% over the past three years , -3% over the past five years , and -11% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.